Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age18+
SponsorSociété Internationale d'Urologie
About this trial
Benign prostatic hyperplasia (BPH) is one of the most common performed surgical procedures in urology. Over the past few decades there have been an increasing development of newer surgical treatment options. Additionally, the outcome parameters for BPH treatments have been standardized. While data are available for the initial pivotal studies, post-market release data are lacking. Under the umbrella of uCARE, we have started a prospective, ongoing international registry for recording demographics and outcomes for patients undergoing surgical treatments for BPH.
Eligibility criteria
Qualifiers
Primary diagnosis of BPH with LUTS with prescribed medical treatment or surgical intervention
Disqualifiers
Non-symptomatic BPH
No treatment prescribed for BPH
Trial design
Treatments tested in this trial
- Not listed
Trial groups
7,500 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov